Company Performance: Profitability, revenue growth, and debt levels directly influence investor confidence and thus the stock price. Strong financials typically lead to higher valuations.

Industry Trends: The performance of the broader pharmaceutical and healthcare sector impacts 600064.SHG. Positive industry outlook often translates to increased stock demand.

Regulatory Environment: Changes in healthcare regulations, drug approvals, and pricing policies can significantly affect the company's future earnings and investor sentiment.

Market Sentiment: General economic conditions, investor risk appetite, and overall market trends play a role in stock valuation. Bull markets typically support higher prices.

Competition: The competitive landscape within the pharmaceutical industry impacts market share and pricing power. The emergence of new competitors can affect profitability.

Global Factors: International economic conditions, trade policies, and global health crises can influence the demand for pharmaceutical products and impact the stock price.

R&D Pipeline: The success of new drug development efforts and the strength of the company's research and development pipeline are critical drivers of future growth and investor confidence.

Management Decisions: Strategic decisions by company management, such as mergers, acquisitions, and capital allocation, influence investor perceptions and stock performance.

Dividend Policy: Dividends, or lack thereof, affect investor returns. Increased dividend payouts can attract investors, impacting the stock price positively.